Future thinking

Brexit

Brexhaustion of IP rights - Moving patented products to Europe after Brexit

Changes to the exhaustion of rights doctrine could affect your business after Brexit. Read on to find out how.

Brexit

UK Intellectual Property Office issues guidance notice on SPCs in case of no-deal Brexit

The UK Intellectual Property Office has posted a guidance notice on its website on 8 March 2019 relating to the situation for Supplementary Protection Certificates (SPCs) if the UK leaves the European Union (EU) without a deal.

Thoughts

Femtech: The next big market disruptor is here, and it’s fearlessly female

Femtech, or Female Technology, is the merging of modern technology and women’s health to address age-old issues. The market is booming, and it’s long overdue. Here we look at the recent market growth, map the development of femtech through patent milestones, and ask -  where next?

An act of balance: Voices of leading female trailblazers

This year, International Women´s Day runs under the themes #BalanceforBetter. How is it possible that in this day and age, we still don’t live in a world of gender balance and equal rights?

News

Albert Keyack, former EPO attaché to the United States, joins Kilburn & Strode to expand the firm’s US offering

Top-tier European IP firm Kilburn & Strode further expands its reach into the US with the hire of Albert Keyack, former EPO attaché to the United States, as Vice President.

News

Computer simulation - referral to the EPO’s Enlarged Board of Appeal

In a rare referral to the Enlarged Board of Appeal, the EPO’s highest appeal board that decides on points of fundamental importance

News

On the rise of ‘Robin Hood’ pharmacies

2.6 billion British pound sterling. That is the average cost of bringing a new drug to market. Pharmaceutical companies willing and able to make such an investment will, in the first instance, try to protect their intellectual property through patents.

News

Patent eligibility of cultured cells in the US: A European perspective

Michael Newton from our highly respected Life Sciences team has published an article in the journal European Intellectual Property Review (EIPR) titled “Differences in Culture: Expanded Cells Held Patent Eligible in the US”.

News

Patentability of plant products obtained by an essentially biological process

In a decision issued by the Technical Board of Appeal on 5 February 2019 (T 1063/18, 5 December 2018), plant products obtained by an essentially biological process were found to be patentable subject matter.